Principal Securities, Inc. Neogenomics Inc Transaction History
Principal Securities, Inc.
- $4.47 Trillion
- Q1 2025
A detailed history of Principal Securities, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Principal Securities, Inc. holds 50 shares of NEO stock, worth $314. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50
Previous 50
-0.0%
Holding current value
$314
Previous $824,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding NEO
# of Institutions
281Shares Held
127MCall Options Held
942KPut Options Held
172K-
Black Rock Inc. New York, NY19.7MShares$124 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.3MShares$89.7 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny6.72MShares$42.3 Million0.04% of portfolio
-
First Light Asset Management, LLC Edina, MN6.04MShares$38 Million7.36% of portfolio
-
Janus Henderson Group PLC London, X05.74MShares$36.1 Million0.03% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $791M
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...